{
  "url": "https://openlegislation.uk/eu-regulation-2007-108/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2007-108/annex.json",
  "legislation": "eur/2007/108",
  "legislation_title": "Commission Regulation (EC) No 108/2007 of 5 February 2007 amending Regulation (EC) No 1356/2004 as regards the conditions for authorisation of the feed additive Elancoban, belonging to the group of coccidiostats and other medicinal substances (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2007-108",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "Registration number of additive\nName and registration number of person responsible for putting additive into circulation\nAdditive(trade name)\nComposition, chemical formula, description\nSpecies or category of animal\nMaximum age\nMinimum content\nMaximum content\nOther provisions\nEnd of period of authorisation\nProvisional maximum residue limits (MRLs) in the relevant foodstuffs of animal origin\nmg of active substance/kg of complete feedingstuff\nCoccidiostats and other medicinal substances\n‘E 757\nEli Lilly and Company Limited\nMonensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200)\nActive substanc:\nC36H61O11Na\nsodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis, ATCC 15413 in granular form.\nFactor composition:\nMonensin A: not less than 90 %\nMonensin: A + B: not less than 95 %\nAdditive composition:\nGranular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w\nMineral oil 1-3 % w/w\nLimestone granular 13-23 % w/w\nRice hulls or limestone granular qs 100 % w/w\nGranular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w\nMineral oil 1-3 % w/w\nRice hulls or limestone granular qs 100 % w/w\nChickens for fattening\n—\n100\n125\nUse prohibited at least three days before slaughter. Indicate in the instructions for use:\n“Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances”\n30.7.2014\n25 μg monensin sodium/kg of wet skin + fat.\n8 μg monensin sodium/kg of wet liver, kidney and muscle’.\nChickens reared for laying\n16 weeks\n100\n120\nTurkeys\n16 weeks\n60\n100",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2007/108/annex",
    "retrieved_at": "2026-11-01T14:53:06.342844+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}